Harnessing Non-Invasive Cross-Sectional Imaging for Clinical Prognostication, Risk Stratification & Real-Time Responsiveness
Time: 9:20 am
day: Day Two
Details:
- Utilizing cross-sectional imaging to detect bowel damage and fibrosis with potential for early use in clinical trial enrolment
- Exploring the role of intestinal ultrasound as a non-invasive biomarker of early treatment response and prediction
- Debating transmural healing as a target for disease modification
